En bloc and two-lobe techniques for laser endoscopic enucleation of the prostate: retrospective comparative analysis of peri- and postoperative outcomes.


Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 26 06 2019
accepted: 14 08 2019
pubmed: 23 8 2019
medline: 28 2 2020
entrez: 22 8 2019
Statut: ppublish

Résumé

Various techniques can be used for endoscopic enucleation of the prostate (EEP): removal of all nodes as a single unit (en bloc) or a step-by-step removal of adenomatous nodes (two- and three-lobe techniques). The objective of this study was to perform a comparative analysis of en bloc and two-lobe techniques for holmium laser enucleation of the prostate (HoLEP) and thulium fiber laser enucleation of the prostate (ThuFLEP). Retrospective assessment included patients with bladder outlet obstruction (IPSS > 20, Qmax < 10) secondary to BPH treated from January 2013 to December 2018. All the patients were assessed prior to surgery, as well as at 1, 3 and 6 months after surgery. The data of 1115 patients who underwent HoLEP or ThuFLEP were analyzed. Two techniques were used: en bloc (406 patients) and two-lobe (709 patients). Mean prostate volumes were comparable between groups. Mean surgery times (68.8 ± 30.6 min vs 67.4 ± 30.1 min; p = 0.604) and enucleation rates (1.9 ± 0.74 g/min vs 1.9 ± 0.69 g/min; p = 0.217) were also comparable. Morcellation rate was lower in en bloc patients with prostate > 150 cc (2.8 ± 1.1 g/min vs 3.7 ± 2.3 g/min; p < 0.001). At 6 months, no differences in functional outcomes (IPSS, PVR, Qmax and QoL) were found. Outcomes and complication rates of en bloc and two-lobe EEP techniques were comparable. En bloc technique was found to have less favorable outcomes in morcellation rate for prostates > 150 cc. The choice of the technique should depend on surgeon's preferences.

Identifiants

pubmed: 31432393
doi: 10.1007/s11255-019-02259-2
pii: 10.1007/s11255-019-02259-2
doi:

Substances chimiques

Thulium 8RKC5ATI4P

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1969-1974

Références

World J Urol. 2018 Oct;36(10):1663-1671
pubmed: 29730838
Nihon Ika Daigaku Zasshi. 1986 Apr;53(2):212-5
pubmed: 2423551
Urology. 2018 Sep;119:121-126
pubmed: 29894773
BMC Urol. 2018 Oct 12;18(1):87
pubmed: 30314492
J Endourol. 2018 May;32(5):417-423
pubmed: 29430969
Low Urin Tract Symptoms. 2018 Sep;10(3):247-252
pubmed: 28699307
World J Urol. 2009 Aug;27(4):541-5
pubmed: 19184038
World J Urol. 2010 Feb;28(1):45-51
pubmed: 20063164
BJU Int. 2010 Mar;105(5):584-5
pubmed: 20070302
World J Urol. 2016 Oct;34(10):1353-5
pubmed: 27585786
Korean J Urol. 2015 Nov;56(11):769-74
pubmed: 26568795
J Endourol. 1998 Oct;12(5):457-9
pubmed: 9847070
Urology. 2018 Nov;121:51-57
pubmed: 30053397
World J Urol. 2016 Aug;34(8):1175-81
pubmed: 26658753

Auteurs

Dmitry Enikeev (D)

Institute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St, Moscow, Russian Federation, 119991. dvenikeev@gmail.com.

Mark Taratkin (M)

Institute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St, Moscow, Russian Federation, 119991.

Ekaterina Laukhtina (E)

Institute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St, Moscow, Russian Federation, 119991.

Tatyana Alekseeva (T)

Institute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St, Moscow, Russian Federation, 119991.

Olesya Snurnitsyna (O)

Institute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St, Moscow, Russian Federation, 119991.

Natalya Potoldykova (N)

Institute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St, Moscow, Russian Federation, 119991.

Andrey Gerasimov (A)

Department of Medical Statistics, Sechenov University, Moscow, Russian Federation.

Petr Glybochko (P)

Institute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St, Moscow, Russian Federation, 119991.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH